Found: 16
Select item for more details and to access through your institution.
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 2, p. 199, doi. 10.1093/nop/npad068
- By:
- Publication type:
- Article
Human cytomegalovirus antigens in malignant gliomas as targets for adoptive cellular therapy.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00338
- By:
- Publication type:
- Article
The safety and accuracy of intratumoral catheter placement to infuse viral immunotherapies in children with malignant brain tumors: a multi-institutional study.
- Published in:
- Journal of Neurosurgery: Pediatrics, 2024, v. 33, n. 4, p. 359, doi. 10.3171/2023.12.PEDS23404
- By:
- Publication type:
- Article
Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 1, p. 5, doi. 10.1093/nop/npad061
- By:
- Publication type:
- Article
Incidence and survival of choroid plexus tumors in the United States.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 1, p. 41, doi. 10.1093/nop/npac062
- By:
- Publication type:
- Article
Epidemiology of pineoblastoma in the United States, 2000–2017.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 2, p. 149, doi. 10.1093/nop/npac009
- By:
- Publication type:
- Article
Assisted reproductive technology and association with childhood cancer subtypes.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 3410, doi. 10.1002/cam4.5114
- By:
- Publication type:
- Article
EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi102, doi. 10.1093/neuonc/noy148.426
- By:
- Publication type:
- Article
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Complications of implantable venous access devices in patients with sickle cell disease.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 2, p. 224, doi. 10.1002/ajh.22230
- By:
- Publication type:
- Article
Consumption of dietary fat causes loss of olfactory sensory neurons and associated circuitry that is not mitigated by voluntary exercise in mice.
- Published in:
- Journal of Physiology, 2022, v. 600, n. 6, p. 1473, doi. 10.1113/JP282112
- By:
- Publication type:
- Article
Modulation of Neural Microcircuits That Control Complex Dynamics in Olfactory Networks.
- Published in:
- Frontiers in Cellular Neuroscience, 2021, v. 15, p. 1, doi. 10.3389/fncel.2021.662184
- By:
- Publication type:
- Article
Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 261, doi. 10.1007/s11060-018-2975-5
- By:
- Publication type:
- Article
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 307, doi. 10.1007/s11060-015-1905-z
- By:
- Publication type:
- Article
Novel case of recurrent intraventricular atypical central neurocytoma with prominent gangliogliomatous differentiation in a 10‐year‐old boy with 10 years of follow up.
- Published in:
- 2018
- By:
- Publication type:
- Case Study